Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ingrid Egeland Christensen"'
Autor:
Ingrid Egeland Christensen, Ingrid Jyssum, Anne Therese Tveter, Joseph Sexton, Trung T. Tran, Siri Mjaaland, Grete Birkeland Kro, Tore K. Kvien, David John Warren, Jørgen Jahnsen, Ludvig A. Munthe, Espen A. Haavardsholm, John Torgils Vaage, Gunnveig Grødeland, Fridtjof Lund-Johansen, Kristin Kaasen Jørgensen, Silje Watterdal Syversen, Guro Løvik Goll, Sella Aarrestad Provan
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract Background The durability of vaccine-induced humoral immunity against SARS-CoV-2 in patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressive therapy is not known. The aim of this study was to compare the persistence o
Externí odkaz:
https://doaj.org/article/2b2207460c4140109e9cb9845dae211b
Autor:
Jorgen Jahnsen, Ingrid Egeland Christensen, Joe Sexton, Silje Watterdal Syversen, Guro Løvik Goll, Ingrid Jyssum, Trung T Tran, Kristin Hammersbøen Bjørlykke, Siri Mjaaland, David J Warren, Adity Chopra, Grete Birkeland Kro, Ludvig A Munthe, Gunnveig Grødeland, Kristin Kaasen Jørgensen
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objectives Humoral vaccine responses to SARS-CoV-2 vaccines are impaired and short lasting in patients with immune-mediated inflammatory diseases (IMID) following two vaccine doses. To protect these vulnerable patients against severe COVID-19 disease
Externí odkaz:
https://doaj.org/article/db3e2b7bbced4e1fbd7959d5219a1ed8
Autor:
Pawel Mielnik, Liz Loli, Gunnstein Bakland, Tore K Kvien, Ingrid Egeland Christensen, Siri Lillegraven, Till Uhlig, Sella Aarrestad Provan, Joseph O. Sexton
Publikováno v:
Annals of the Rheumatic Diseases. 81:398-401
Objectives: To estimate the incidence of serious infections (SIs) in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA) treated with tumour necrosis factor inhibitor (TNFi), and compare risk of SIs between patients with RA and PsA.
Autor:
Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, Joe Sexton, Ingrid Egeland Christensen, Trung T Tran, Kristin Hammersbøen Bjørlykke, Siri Mjaaland, David J Warren, Tore K Kvien, Adity Chopra, Grete Birkeland Kro, Jorgen Jahnsen, Ludvig A Munthe, Espen A Haavardsholm, Gunnveig Grødeland, John Torgils Vaage, Sella Aarrestad Provan, Kristin Kaasen Jørgensen, Guro Løvik Goll
Publikováno v:
RMD Open
ObjectivesHumoral vaccine responses to SARS-CoV-2 vaccines are impaired and short lasting in patients with immune-mediated inflammatory diseases (IMID) following two vaccine doses. To protect these vulnerable patients against severe COVID-19 disease,